210 results on '"Ghali, Fady"'
Search Results
2. Disparities in Telemedicine Utilization for Urology Patients During the COVID-19 Pandemic.
3. Adjuvant Chemotherapy and Survival After Radical Cystectomy in Histologic Subtype Bladder Cancer
4. Metastatic Bladder Cancer Expression and Subcellular Localization of Nectin-4 and Trop-2 in Variant Histology: A Rapid Autopsy Study
5. Surrogate Endpoints as Predictors of Overall Survival in Metastatic Urothelial Cancer: A Trial-level Analysis
6. Impact of Metastasectomy on Cancer Specific and Overall Survival in Metastatic Renal Cell Carcinoma: Analysis of the REMARCC Registry
7. Clinical Trial Considerations for Bladder Preservation in Muscle-Invasive Bladder Cancer
8. Disparities in Cancer Specific and Overall Survival Outcomes in African Americans With Renal Cell Carcinoma: Analysis From the International Marker Consortium for Renal Cancer (INMARC)
9. A Preoperative Nomogram to Predict Renal Function Insufficiency for Cisplatin-based Adjuvant Chemotherapy Following Minimally Invasive Radical Nephroureterectomy (ROBUUST Collaborative Group)
10. Patterns of chemotherapy use with primary radiotherapy for localized bladder cancer in patients 65 or older
11. PD34-09 PATTERNS OF CHEMOTHERAPY USE WITH PRIMARY RADIOTHERAPY FOR LOCALIZED BLADDER CANCER
12. Evaluating Treatment Patterns and the Role of Neoadjuvant Chemotherapy in Plasmacytoid Urothelial Carcinoma: Insights from a Combined National and Institutional Series.
13. Oncologic and Functional Outcomes of Radical and Partial Nephrectomy in pT3a Pathologically Upstaged Renal Cell Carcinoma: A Multi-institutional Analysis
14. Risk Factors for Upstaging, Recurrence, and Mortality in Clinical T1-2 Renal Cell Carcinoma Patients Upstaged to pT3a Disease: An International Analysis Utilizing the 8th Edition of the Tumor-Node-Metastasis Staging Criteria
15. Comparison of renal functional outcomes of active surveillance and partial nephrectomy in the management of oncocytoma
16. Robotic partial nephrectomy for clinical T2a renal mass is associated with improved trifecta outcome compared to open partial nephrectomy: a single surgeon comparative analysis
17. A novel ex vivo trainer for robotic vesicourethral anastomosis
18. Diagnosis, management, and follow-up of upper tract urothelial carcinoma: an interdisciplinary collaboration between urology and radiology
19. Practice Makes Perfect: Correlations Between Prior Experience in High-level Athletics and Robotic Surgical Performance Do Not Persist After Task Repetition
20. Evaluation of the association of health care system access with kidney cancer surgical outcomes for hispanic and non-hispanic white patients
21. Pathologic nodal downstaging in men with clinically involved lymph nodes undergoing radical prostatectomy: Implications for definitive locoregional therapy
22. Unplanned Hospital Return for Infection following Ureteroscopy—Can We Identify Modifiable Risk Factors?
23. Utilization of renal mass biopsy in patients with localized renal cell carcinoma: A population-based study utilizing the National Cancer Database
24. The Pursuit of Intravesical and Systemic Therapies in Non–muscle-invasive Bladder Cancer: Challenges and Opportunities
25. Corrigendum re “A Preoperative Nomogram to Predict Renal Function Insufficiency for Cisplatin-based Adjuvant Chemotherapy Following Minimally Invasive Radical Nephroureterectomy (ROBUUST Collaborative Group)” [Eur Urol Focus 2022;8:173–81]
26. External validation of yonsei nomogram predicting chronic kidney disease development after partial nephrectomy: An international, multicenter study
27. List of Contributors
28. Penile Fibrogenesis Affecting Men’s Reproductive and Sexual Health
29. Does Travel Time to a Radiation Facility Impact Patient Decision‐Making Regarding Treatment for Prostate Cancer? A Study of the New Hampshire State Cancer Registry
30. MP56-20 SURROGATE ENDPOINTS AS PREDICTORS OF SURVIVAL IN METASTATIC UROTHELIAL CANCER TRIALS
31. PD53-09 ANTIBODY DRUG CONJUGATES AND VARIANT HISTOLOGY MUSCLE-INVASIVE BLADDER CANCER: ARE THE TARGETS PRESENT IN PRIMARY AND/OR METASTATIC TUMORS?
32. PD15-07 RENAL CELL CARCINOMA PARANEOPLASTIC SYNDROME SCORE: CONSTRUCTION AND VALIDATION
33. Disparities in Telemedicine Utilization for Urology Patients During the COVID-19 Pandemic
34. Corrigendum re “A Preoperative Nomogram to Predict Renal Function Insufficiency for Cisplatin-based Adjuvant Chemotherapy Following Minimally Invasive Radical Nephroureterectomy (ROBUUST Collaborative Group)” [Eur Urol Focus 2022;8:173–81]
35. Techniques of robotic assisted partial nephrectomy with renal vein tumor thrombectomy and reconstruction: UCSD experience
36. Warm ischemia time length during on-clamp partial nephrectomy: does it really matter?
37. Does presence of diabetes mellitus impact patient oncological outcomes in renal cell carcinoma: A multicenter analysis.
38. PRIOR EXPERIENCE IN ATHLETICS IS SIGNIFICANTLY ASSOCIATED WITH INCREASED ROBOTIC SURGICAL SKILL IN ROBOT-NAIVE MEDICAL STUDENTS: MP11-09
39. External validation of yonsei nomogram predicting chronic kidney disease development after partial nephrectomy: An international, multicenter study.
40. MP26-16 PERFORMANCE OF PROMPT-PROSTATE GENETIC SCORE IN A JAPANESE COHORT
41. Re: Association of Black Race with Prostate Cancer–specific and Other-cause Mortality
42. MP45-05 IMPACT OF ELEVATED C-REACTIVE PROTEIN ON SURVIVAL OUTCOMES IN SMALL RENAL MASSES: ANALYSIS OF THE INMARC REGISTRY
43. MP45-12 THE ASSOCIATION BETWEEN THE AFFORDABLE CARE ACT ON INSURANCE STATUS, CANCER STAGE, AND OVERALL SURVIVAL IN PATIENTS WITH RENAL CELL CARCINOMA
44. MP42-17 ASSOCIATION OF TUMOR HISTOLOGY ON IMPACT OF LYMPH NODE DISSECTION ON SURVIVAL IN T2-T3 RENAL CELL CARCINOMA: ANALYSIS OF THE NATIONAL CANCER DATABASE
45. V11-07 TECHNIQUES OF ROBOTIC ASSISTED PARTIAL NEPHRECTOMY WITH RENAL VEIN TUMOR THROMBECTOMY AND RECONSTRUCTION: UCSD EXPERIENCE
46. MP66-15 PATIENT-CENTRIC 3 DIMENSIONAL-BIOSYSTEMS FOR DEVELOPING PERSONALIZED IMMUNOTHERAPY FOR PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA
47. Clinical Trials and Climate Change: Doing Our Part While Pursuing Progress
48. Evaluation of Insurance Coverage and Cancer Stage at Diagnosis Among Low-Income Adults With Renal Cell Carcinoma After Passage of the Patient Protection and Affordable Care Act
49. Impact of positive surgical margins on survival after partial nephrectomy in localized kidney cancer: analysis of the National Cancer Database
50. Heterotopic Pancreatic Tail Appearing as Adrenal Mass in a Patient With Left Pelvic Kidney
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.